More Orthocell Ltd news
Orthocell LtdASX: OCC

Celgro Positive Safety and Performance in Human Hip Study

Sep 5, 2017 at 11:48 PM EDT · Issued by Orthocell Ltd

Filed with ASX · Sep 5, 2017 at 11:48 PM EDT

On 6ix: 6ix.com/news/celgro-positive-safety-and-performance-in-human-hip-study

Orthocell Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Orthocell Ltd on 6ix

Story so far

  • Orthocell Receives Approval for Human Hip Study Using CelgroMay 4, 2016

Earlier from Orthocell

  • 1st Patient Recruited in Ortho-ATI Shoulder Tendon StudySep 4, 2017
  • Preliminary Final ReportAug 31, 2017
  • Ortho-ACI on Australian Register of Therapeutic GoodsMay 29, 2017
  • Ethics Approval Received for Pilot Ortho-ATI Tendon StudyApr 30, 2017
  • Response to ASX QueryApr 10, 2017

Later from Orthocell

  • Surgical Specialties Appointed as Exclusive DistributorOct 10, 2017
  • Notice of Annual General Meeting/Proxy FormOct 13, 2017
  • Orthocell Granted CelGro Patent Protection in CanadaOct 15, 2017
  • Orthocell receives R&D tax incentive refundOct 23, 2017
  • Orthocell Receives CE Mark for CelGroNov 8, 2017
All Orthocell news releases↗

Follow Orthocell into a list and get an email when it puts out news.

Follow Orthocell
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer